4.1 ZSM-5 is a siliceous zeolite that can be crystallized with SiO₂/Al₂O₃ ratio in the range of 20 to greater than 1000. ZSM-5, upon modification to the H-cation form (HZSM-5) in a post-crystallization step, has been used since the 1970s as a shape selective, acid-site catalyst for petroleum refining and petrochemicals production, including such processes as alkylation, isomerization, fluid cracking catalysis (FCC), and methanol-to-gasoline. The most siliceous member of the ZSM-5 family, sometimes called silicalite, is hydrophobic and it is used for selective sorption of organic molecules from water-containing systems.

4.2 This X-ray procedure is designed to allow a reporting of the relative degree of crystallization upon manufacture of ZSM-5. The relative crystallinity/ZSM-5 number has proven useful in technology, research, and specifications.

4.3 The Integrated Peak Area Method (Procedure A) is preferred over the Peak Height Method (Procedure B) since it calculates XRD intensity as a sum from several peaks rather than utilizing just one peak. Drastic changes in intensity of individual peaks in the XRD pattern of ZSM-5 can result from changes in distribution of electron density within the unit cell of the ZSM-5 zeolite. The electron density distribution is dependent upon the following factors:

4.3.1 Extent of filling of pores with guest molecules and the nature of these guest molecules.

4.3.2 Type of cations and extent of their presence (these cations may also affect the absorption of X rays by the ZSM-5 sample).

4.3.3 In this XRD method, the guest molecule H₂O completes the filling of the pores. Other guest molecule types may also be present, including one of numerous amines, diamines, and quarternary ammonium cations that can function as a template for crystallization of the ZSM-5 structure.

4.3.4 Because of the factors mentioned in 4.3.1 to 4.3.3 that could vary the intensities of the XRD peaks in ZSM-5, this XRD method will provide the best determination of relative crystallinity when the reference ZSM-5 and sample ZSM-5 have a similar history of preparation and composition.

4.4 ZSM-5 can exist with either orthorhombic or monoclinic symmetry, depending upon the composition of the precursor gel or post-crystallization modification conditions, or both. In the orthorhombic type, the XRD peaks centered at about 23.1 and 23.8° 2θ are usually split into doublets, whereas the less symmetric monoclinic type may show a further split of these peaks into triplets. The peak area intensities of these peaks are unaffected by the crystalline form. The XRD peak at 24.3° 2θ for the orthorhombic form is a singlet and hence is the most suitable for the Peak Height Method (Procedure B). If the 24.3° peak is split (doublet in the monoclinic form), then the Integrated Peak Area Method (Procedure A) should be used.

4.5 If crystalline phases other than ZSM-5 are present in the sample, their diffraction peaks may overlap with some of the ZSM-5 peaks selected for the Integrated Peak Area Method (Procedure A). If there is reason to suspect the presence of such components, then the Peak Height Method (Procedure B) should be chosen for analysis provided that there is no interference with the 24.3° 2θ peak that is used for the calculation.

1.1 This test method covers a procedure for determination of the relative crystallinity of zeolite ZSM-5 using selected peaks from the X-ray diffraction pattern of the zeolite.

1.2 The test method provides a number that is the ratio of intensity of a portion of the XRD pattern of the sample ZSM-5 to intensity of the corresponding portion of the pattern of a reference ZSM-5. The intensity ratio, expressed as a percentage, is then labeled percent XRD relative crystallinity/ZSM-5. This type of comparison is commonly used in zeolite technology and is often referred to as percent crystallinity.

1.3 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.